Alpine Immune Sciences Cash from Financing (TTM) Insights

Alpine Immune Sciences Inc (ALPN)

64.60 0.00 (0.00%) USD | NASDAQ | May 03, 16:00

64.60 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	165.12M
September 30, 2023	20.06M
June 30, 2023	111.67M
March 31, 2023	102.25M
December 31, 2022	102.69M
September 30, 2022	102.02M
June 30, 2022	98.88M
March 31, 2022	99.91M
December 31, 2021	100.76M
September 30, 2021	89.88M
June 30, 2021	56.59M
March 31, 2021	56.58M
December 31, 2020	61.38M
September 30, 2020	61.39M
June 30, 2020	6.648M
March 31, 2020	6.137M
December 31, 2019	24.26M
September 30, 2019	23.76M
June 30, 2019	21.61M

Date	Value
March 31, 2019	22.12M
December 31, 2018	-0.991M
September 30, 2018	-0.491M
June 30, 2018	42.70M
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014	41.17M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

6.137M

Minimum

Mar 2020

165.12M

Maximum

Dec 2023

69.03M

Average

61.39M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks